Please assess the completion status of the following clinical trial:

Trial Title: CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years or older.~* Undergoing FFR assessment for standard clinical indications.~* Ability to understand and willingness to sign a written informed consent.~Exclusion Criteria:~* Prior coronary artery bypass grafting (CABG).~* Extremely tortuous or calcified coronary arteries precluding intracoronary physiologic measurements. Operators may exclude subtotal or similar high-grade lesions, which in their judgment may be threatened by pressure wire placement.~* Known severe left ventricular hypertrophy (septal wall thickness at echocardiography of \>13 mm).~* Inability to receive adenosine (for example, severe reactive airway disease, marked hypotension, or advanced atrioventricular block without pacemaker).~* Recent (within 3 weeks prior to cardiac catheterization) ST-segment elevation myocardial infarction (STEMI) in any arterial distribution (not specifically target lesion).~* Culprit lesions (based on clinical judgment of the operator) for either STEMI or non-STEMI cannot be included.~* Severe cardiomyopathy (ejection fraction \<30%).~* Renal insufficiency such that an additional 12 to 20 mL of contrast would, in the opinion of the operator, pose unwarranted risk to the patient.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- All patients (Type: None): Entire cohort undergoes paired testing

Based on this trial design, predict the completion outcome and termination type (if applicable).